EADock: Docking of small molecules into protein active sites with a multiobjective evolutionary optimization

被引:151
作者
Grosdidier, Aurelien [1 ]
Zoete, Vincent [1 ]
Michielin, Olivier [1 ]
机构
[1] SIB, Mol Modeling Grp, CH-1015 Lausanne, Switzerland
关键词
small ligand docking; evolutionary algorithms; rational drug design; EADock;
D O I
10.1002/prot.21367
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In recent years, protein-ligand docking has become a powerful tool for drug development. Although several approaches suitable for high throughput screening are available, there is a need for methods able to identify binding modes with high accuracy. This accuracy is essential to reliably compute the binding free energy of the ligand. Such methods are needed when the binding mode of lead compounds is not determined experimentally but is needed for structure-based lead optimization. We present here a new docking software, called EADock, that aims at this goal. It uses an hybrid evolutionary algorithm with two fitness functions, in combination with a sophisticated management of the diversity. EADock is interfaced with the CHARMM package for energy calculations and coordinate handling. A validation was carried out on 37 crystallized protein-ligand complexes featuring 11 different proteins. The search space was defined as a sphere of 15 angstrom around the center of mass of the ligand position in the crystal structure, and on the contrary to other benchmarks, our algorithm was fed with optimized ligand positions up to 10 angstrom root mean square deviation (RMSD) from the crystal structure, excluding the latter. This validation illustrates the efficiency of our sampling strategy, as correct binding modes, defined. by a RMSD to the crystal structure lower than 2 angstrom, were identified and ranked first for 68% of the complexes. The success rate increases to 78% when considering the five best ranked clusters, and 92% when all clusters present in the last generation are taken into account. Most failures could be explained by the presence of crystal contacts in the experimental structure. Finally, the ability of EADock to accurately predict binding modes on a real application was illustrated by the successful docking of the RGD cyclic pentapeptide on the alpha V beta 3 integrin, starting far away from the binding pocket. Proteins 2007;67:1010-1025. (C) 2007 Wiley-Liss, Inc.
引用
收藏
页码:1010 / 1025
页数:16
相关论文
共 66 条
  • [31] 2-T
  • [32] Halgren TA, 1996, J COMPUT CHEM, V17, P587, DOI 10.1002/(SICI)1096-987X(199604)17:5/6<587::AID-JCC4>3.0.CO
  • [33] 2-Q
  • [34] Hasel W, 1988, TETRAHEDRON COMPUT M, V1, P103, DOI DOI 10.1016/0898-5529(88)90015-2
  • [35] VALIDATE: A new method for the receptor-based prediction of binding affinities of novel ligands
    Head, RD
    Smythe, ML
    Oprea, TI
    Waller, CL
    Green, SM
    Marshall, GR
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1996, 118 (16) : 3959 - 3969
  • [37] A-PRIORI PREDICTION OF ACTIVITY FOR HIV-1 PROTEASE INHIBITORS EMPLOYING ENERGY MINIMIZATION IN THE ACTIVE-SITE
    HOLLOWAY, MK
    WAI, JM
    HALGREN, TA
    FITZGERALD, PMD
    VACCA, JP
    DORSEY, BD
    LEVIN, RB
    THOMPSON, WJ
    CHEN, LJ
    DESOLMS, SJ
    GAFFIN, N
    GHOSH, AK
    GIULIANI, EA
    GRAHAM, SL
    GUARE, JP
    HUNGATE, RW
    LYLE, TA
    SANDERS, WM
    TUCKER, TJ
    WIGGINS, M
    WISCOUNT, CM
    WOLTERSDORF, OW
    YOUNG, SD
    DARKE, PL
    ZUGAY, JA
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (02) : 305 - 317
  • [38] Discovery of cell-permeable non-peptide inhibitors of β-secretase by high-throughput docking and continuum electrostatics calculations
    Huang, DZ
    Lüthi, U
    Kolb, P
    Edler, K
    Cecchini, M
    Audetat, S
    Barberis, A
    Caflisch, A
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (16) : 5108 - 5111
  • [39] Development and validation of a genetic algorithm for flexible docking
    Jones, G
    Willett, P
    Glen, RC
    Leach, AR
    Taylor, R
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 1997, 267 (03) : 727 - 748
  • [40] Docking and scoring in virtual screening for drug discovery: Methods and applications
    Kitchen, DB
    Decornez, H
    Furr, JR
    Bajorath, J
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (11) : 935 - 949